CN Stock MarketDetailed Quotes

002294 Shenzhen Salubris Pharmaceuticals

Watchlist
  • 33.97
  • -0.21-0.61%
Market Closed Dec 13 15:00 CST
37.87BMarket Cap61.99P/E (TTM)

Shenzhen Salubris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
22.10%3.09B
19.92%2.07B
24.33%1.05B
-0.53%3.49B
-1.92%2.53B
2.49%1.72B
-1.85%842.53M
6.97%3.51B
13.09%2.58B
23.06%1.68B
Refunds of taxes and levies
188.16%14.54M
149.93%4.35M
--7.4K
-67.13%7.69M
-78.55%5.05M
-91.84%1.74M
----
-25.08%23.4M
-8.30%23.52M
-12.31%21.35M
Cash received relating to other operating activities
-22.55%112.75M
-46.51%65.15M
-38.22%34.97M
4.86%173.78M
0.74%145.57M
41.07%121.8M
30.64%56.6M
7.85%165.72M
-4.15%144.51M
86.60%86.34M
Cash inflows from operating activities
19.99%3.22B
15.66%2.14B
20.40%1.08B
-0.71%3.67B
-2.44%2.68B
3.22%1.85B
-0.55%899.13M
6.72%3.7B
11.81%2.75B
24.50%1.79B
Goods services cash paid
-6.07%456.46M
-15.92%288.63M
-12.97%129.84M
-2.38%590.69M
14.79%485.93M
20.94%343.28M
1.09%149.19M
22.48%605.1M
25.28%423.32M
19.46%283.85M
Staff behalf paid
9.79%737.73M
7.09%523.5M
9.52%317.42M
14.61%873.65M
12.52%671.93M
16.60%488.82M
19.09%289.83M
2.92%762.3M
8.02%597.16M
6.82%419.23M
All taxes paid
11.03%353.19M
9.90%251.32M
10.75%134.43M
-3.17%414.11M
-1.06%318.09M
2.18%228.69M
16.56%121.38M
20.35%427.65M
32.59%321.49M
33.30%223.8M
Cash paid relating to other operating activities
21.71%813.96M
24.72%539M
26.89%270.7M
2.32%953.49M
-5.15%668.75M
-4.69%432.16M
-12.46%213.34M
35.07%931.86M
49.85%705.08M
40.98%453.41M
Cash outflows from operating activities
10.10%2.36B
7.34%1.6B
10.16%852.39M
3.85%2.83B
4.77%2.14B
8.16%1.49B
4.73%773.74M
19.60%2.73B
27.64%2.05B
23.29%1.38B
Net cash flows from operating activities
59.63%853.91M
50.81%533.06M
83.54%230.13M
-13.53%839.44M
-23.53%534.95M
-13.46%353.46M
-24.13%125.38M
-18.07%970.8M
-17.96%699.56M
28.81%408.45M
Investing cash flow
Cash received from disposal of investments
56.95%1.17B
20.79%736.59M
-32.39%155M
104.67%1.41B
119.40%745.12M
92.55%609.79M
227.51%229.25M
16.47%689.03M
-32.92%339.61M
-21.90%316.7M
Cash received from returns on investments
186.93%23.64M
293.70%21.29M
46.64%2.8M
326.03%30.35M
337.42%8.24M
316.56%5.41M
1,174.92%1.91M
-59.82%7.12M
-84.64%1.88M
-88.74%1.3M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
3.36%315.03K
-20.00%165.03K
-70.93%11.94K
-0.44%583.54K
-35.68%304.8K
-33.42%206.28K
-25.01%41.07K
-63.20%586.12K
-48.13%473.87K
-34.77%309.83K
Cash inflows from investing activities
58.35%1.19B
23.18%758.04M
-31.74%157.81M
106.84%1.44B
120.39%753.66M
93.34%615.41M
229.33%231.2M
14.05%696.74M
-34.17%341.97M
-23.76%318.31M
Cash paid to acquire fixed assets intangible assets and other long-term assets
-14.24%444.41M
27.56%271.05M
11.17%114.36M
12.03%671M
19.86%518.22M
-25.07%212.49M
-40.46%102.87M
24.14%598.96M
18.77%432.35M
10.07%283.59M
Cash paid to acquire investments
90.77%1.96B
45.00%1.16B
-59.01%150M
56.15%2.14B
330.13%1.03B
712.93%800.95M
525.20%365.9M
175.28%1.37B
-33.06%238.53M
-39.81%98.53M
Cash paid relating to other investing activities
--13.43K
----
----
----
----
----
----
----
----
----
Cash outflows from investing activities
55.53%2.4B
41.34%1.43B
-43.61%264.36M
42.74%2.81B
130.18%1.54B
165.22%1.01B
102.67%468.78M
100.91%1.97B
-6.87%670.87M
-9.31%382.12M
Net cash flows from investing activities
-52.84%-1.21B
-69.42%-674.36M
55.15%-106.55M
-7.66%-1.37B
-140.35%-790.54M
-523.75%-398.03M
-47.47%-237.58M
-244.47%-1.27B
-63.71%-328.9M
-1,572.51%-63.81M
Financing cash flow
Cash received from capital contributions
328.30%134.72K
----
----
-99.91%31.45K
32.64%31.45K
-15.76%19.98K
----
-98.22%34.47M
-100.00%23.71K
-100.00%23.71K
-Including: Cash received from capital contributions by minority shareholders of subsidiaries
328.30%134.72K
----
----
-99.91%31.45K
32.64%31.45K
-15.76%19.98K
----
--34.47M
--23.71K
--23.71K
Cash from borrowing
-73.33%59.66M
-89.45%10M
----
-24.50%223.73M
-9.20%223.73M
-58.13%94.8M
-74.10%35.8M
-2.49%296.33M
-6.28%246.4M
-0.66%226.4M
Cash received relating to other financing activities
--601.92M
--22.16M
----
----
----
----
----
-23.41%300.5M
-23.41%300.5M
----
Cash inflows from financing activities
195.72%661.72M
-66.08%32.16M
----
-64.56%223.76M
-59.09%223.76M
-58.12%94.82M
-74.10%35.8M
-76.04%631.31M
-78.87%546.92M
-91.13%226.42M
Borrowing repayment
-81.08%39.84M
-77.20%39.84M
-80.11%29.84M
95.33%358.63M
39.98%210.53M
181.83%174.73M
614.49%150.04M
-71.29%183.6M
-72.48%150.4M
-79.51%62M
Dividend interest payment
-0.72%545.95M
-58.44%228.22M
-97.28%92.26K
24.81%550.68M
24.94%549.9M
197.28%549.15M
159.91%3.39M
2,582.98%441.21M
4,647.94%440.14M
2,556.87%184.72M
-Including:Cash payments for dividends or profit to minority shareholders
----
----
----
12,145.28%1.31M
--626.7K
--462.51K
--462.51K
-98.82%10.67K
----
----
Cash payments relating to other financing activities
-0.29%10.68M
-2.98%7.26M
-6.04%3.89M
-95.11%19.96M
-97.31%10.71M
-98.11%7.48M
-98.29%4.15M
-5.28%408M
62.52%397.84M
5,452.42%394.64M
Cash outflows from financing activities
-22.65%596.46M
-62.36%275.31M
-78.53%33.83M
-10.03%929.27M
-21.98%771.15M
14.03%731.36M
-40.45%157.58M
-4.96%1.03B
23.46%988.39M
102.53%641.36M
Net cash flows from financing activities
111.92%65.25M
61.80%-243.15M
72.22%-33.83M
-75.72%-705.5M
-23.99%-547.38M
-53.41%-636.54M
3.68%-121.78M
-125.93%-401.5M
-124.69%-441.46M
-118.55%-414.94M
Net cash flow
Exchange rate change effecting cash and cash equivalents
-149.29%-4.77M
-80.67%2.4M
107.99%617.81K
-87.66%4.07M
-77.90%9.68M
-35.17%12.4M
-684.53%-7.73M
586.53%32.96M
59,659.75%43.78M
948.43%19.12M
Net increase in cash and cash equivalents
62.96%-293.86M
42.87%-382.05M
137.39%90.37M
-83.72%-1.23B
-2,835.58%-793.3M
-1,206.67%-668.72M
-96.11%-241.7M
-128.47%-671.04M
-101.11%-27.02M
-102.01%-51.18M
Add:Begin period cash and cash equivalents
-48.33%1.32B
-48.33%1.32B
-48.33%1.32B
-20.83%2.55B
-20.83%2.55B
-20.83%2.55B
-20.83%2.55B
272.43%3.22B
272.43%3.22B
272.43%3.22B
End period cash equivalent
-41.72%1.02B
-50.27%936.11M
-39.01%1.41B
-48.33%1.32B
-44.99%1.76B
-40.64%1.88B
-25.48%2.31B
-20.83%2.55B
-3.34%3.19B
-7.10%3.17B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash 22.10%3.09B19.92%2.07B24.33%1.05B-0.53%3.49B-1.92%2.53B2.49%1.72B-1.85%842.53M6.97%3.51B13.09%2.58B23.06%1.68B
Refunds of taxes and levies 188.16%14.54M149.93%4.35M--7.4K-67.13%7.69M-78.55%5.05M-91.84%1.74M-----25.08%23.4M-8.30%23.52M-12.31%21.35M
Cash received relating to other operating activities -22.55%112.75M-46.51%65.15M-38.22%34.97M4.86%173.78M0.74%145.57M41.07%121.8M30.64%56.6M7.85%165.72M-4.15%144.51M86.60%86.34M
Cash inflows from operating activities 19.99%3.22B15.66%2.14B20.40%1.08B-0.71%3.67B-2.44%2.68B3.22%1.85B-0.55%899.13M6.72%3.7B11.81%2.75B24.50%1.79B
Goods services cash paid -6.07%456.46M-15.92%288.63M-12.97%129.84M-2.38%590.69M14.79%485.93M20.94%343.28M1.09%149.19M22.48%605.1M25.28%423.32M19.46%283.85M
Staff behalf paid 9.79%737.73M7.09%523.5M9.52%317.42M14.61%873.65M12.52%671.93M16.60%488.82M19.09%289.83M2.92%762.3M8.02%597.16M6.82%419.23M
All taxes paid 11.03%353.19M9.90%251.32M10.75%134.43M-3.17%414.11M-1.06%318.09M2.18%228.69M16.56%121.38M20.35%427.65M32.59%321.49M33.30%223.8M
Cash paid relating to other operating activities 21.71%813.96M24.72%539M26.89%270.7M2.32%953.49M-5.15%668.75M-4.69%432.16M-12.46%213.34M35.07%931.86M49.85%705.08M40.98%453.41M
Cash outflows from operating activities 10.10%2.36B7.34%1.6B10.16%852.39M3.85%2.83B4.77%2.14B8.16%1.49B4.73%773.74M19.60%2.73B27.64%2.05B23.29%1.38B
Net cash flows from operating activities 59.63%853.91M50.81%533.06M83.54%230.13M-13.53%839.44M-23.53%534.95M-13.46%353.46M-24.13%125.38M-18.07%970.8M-17.96%699.56M28.81%408.45M
Investing cash flow
Cash received from disposal of investments 56.95%1.17B20.79%736.59M-32.39%155M104.67%1.41B119.40%745.12M92.55%609.79M227.51%229.25M16.47%689.03M-32.92%339.61M-21.90%316.7M
Cash received from returns on investments 186.93%23.64M293.70%21.29M46.64%2.8M326.03%30.35M337.42%8.24M316.56%5.41M1,174.92%1.91M-59.82%7.12M-84.64%1.88M-88.74%1.3M
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset 3.36%315.03K-20.00%165.03K-70.93%11.94K-0.44%583.54K-35.68%304.8K-33.42%206.28K-25.01%41.07K-63.20%586.12K-48.13%473.87K-34.77%309.83K
Cash inflows from investing activities 58.35%1.19B23.18%758.04M-31.74%157.81M106.84%1.44B120.39%753.66M93.34%615.41M229.33%231.2M14.05%696.74M-34.17%341.97M-23.76%318.31M
Cash paid to acquire fixed assets intangible assets and other long-term assets -14.24%444.41M27.56%271.05M11.17%114.36M12.03%671M19.86%518.22M-25.07%212.49M-40.46%102.87M24.14%598.96M18.77%432.35M10.07%283.59M
Cash paid to acquire investments 90.77%1.96B45.00%1.16B-59.01%150M56.15%2.14B330.13%1.03B712.93%800.95M525.20%365.9M175.28%1.37B-33.06%238.53M-39.81%98.53M
Cash paid relating to other investing activities --13.43K------------------------------------
Cash outflows from investing activities 55.53%2.4B41.34%1.43B-43.61%264.36M42.74%2.81B130.18%1.54B165.22%1.01B102.67%468.78M100.91%1.97B-6.87%670.87M-9.31%382.12M
Net cash flows from investing activities -52.84%-1.21B-69.42%-674.36M55.15%-106.55M-7.66%-1.37B-140.35%-790.54M-523.75%-398.03M-47.47%-237.58M-244.47%-1.27B-63.71%-328.9M-1,572.51%-63.81M
Financing cash flow
Cash received from capital contributions 328.30%134.72K---------99.91%31.45K32.64%31.45K-15.76%19.98K-----98.22%34.47M-100.00%23.71K-100.00%23.71K
-Including: Cash received from capital contributions by minority shareholders of subsidiaries 328.30%134.72K---------99.91%31.45K32.64%31.45K-15.76%19.98K------34.47M--23.71K--23.71K
Cash from borrowing -73.33%59.66M-89.45%10M-----24.50%223.73M-9.20%223.73M-58.13%94.8M-74.10%35.8M-2.49%296.33M-6.28%246.4M-0.66%226.4M
Cash received relating to other financing activities --601.92M--22.16M---------------------23.41%300.5M-23.41%300.5M----
Cash inflows from financing activities 195.72%661.72M-66.08%32.16M-----64.56%223.76M-59.09%223.76M-58.12%94.82M-74.10%35.8M-76.04%631.31M-78.87%546.92M-91.13%226.42M
Borrowing repayment -81.08%39.84M-77.20%39.84M-80.11%29.84M95.33%358.63M39.98%210.53M181.83%174.73M614.49%150.04M-71.29%183.6M-72.48%150.4M-79.51%62M
Dividend interest payment -0.72%545.95M-58.44%228.22M-97.28%92.26K24.81%550.68M24.94%549.9M197.28%549.15M159.91%3.39M2,582.98%441.21M4,647.94%440.14M2,556.87%184.72M
-Including:Cash payments for dividends or profit to minority shareholders ------------12,145.28%1.31M--626.7K--462.51K--462.51K-98.82%10.67K--------
Cash payments relating to other financing activities -0.29%10.68M-2.98%7.26M-6.04%3.89M-95.11%19.96M-97.31%10.71M-98.11%7.48M-98.29%4.15M-5.28%408M62.52%397.84M5,452.42%394.64M
Cash outflows from financing activities -22.65%596.46M-62.36%275.31M-78.53%33.83M-10.03%929.27M-21.98%771.15M14.03%731.36M-40.45%157.58M-4.96%1.03B23.46%988.39M102.53%641.36M
Net cash flows from financing activities 111.92%65.25M61.80%-243.15M72.22%-33.83M-75.72%-705.5M-23.99%-547.38M-53.41%-636.54M3.68%-121.78M-125.93%-401.5M-124.69%-441.46M-118.55%-414.94M
Net cash flow
Exchange rate change effecting cash and cash equivalents -149.29%-4.77M-80.67%2.4M107.99%617.81K-87.66%4.07M-77.90%9.68M-35.17%12.4M-684.53%-7.73M586.53%32.96M59,659.75%43.78M948.43%19.12M
Net increase in cash and cash equivalents 62.96%-293.86M42.87%-382.05M137.39%90.37M-83.72%-1.23B-2,835.58%-793.3M-1,206.67%-668.72M-96.11%-241.7M-128.47%-671.04M-101.11%-27.02M-102.01%-51.18M
Add:Begin period cash and cash equivalents -48.33%1.32B-48.33%1.32B-48.33%1.32B-20.83%2.55B-20.83%2.55B-20.83%2.55B-20.83%2.55B272.43%3.22B272.43%3.22B272.43%3.22B
End period cash equivalent -41.72%1.02B-50.27%936.11M-39.01%1.41B-48.33%1.32B-44.99%1.76B-40.64%1.88B-25.48%2.31B-20.83%2.55B-3.34%3.19B-7.10%3.17B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%